Short-Term Patient-Reported Outcomes of Multi-Contact Independent Current Control Spinal Cord Stimulation in Patients with Chronic Low Back and Extremity Pain: An Exploratory Prospective Cohort Study
Stereotactic and Functional Neurosurgery · 2025
DOI: 10.1159/000546430 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Stereotactic and Functional Neurosurgery, 2025. Verfasst von Leonard H Verhey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurological Surgery, Department of Clinical Neuroscience, Corewell Health, Grand Rapids, Michigan, USA. Hauptthemen laut MEDLINE: Spinal Cord Stimulation, Patient Reported Outcome Measures, Low Back Pain, Chronic Pain. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
The effect of multi-contact independent current control (MICC) spinal cord stimulation (SCS) on patient-reported outcomes in those who have lost therapeutic efficacy of a conventional SCS is not well described. We prospectively evaluated self-reported pain, disability, and quality of life in patients with persistent spinal pain syndrome type 2 (PSPS-2) who were converted from a conventional to MICC SCS.
Methods
Patients with PSPS-2 who had lost therapeutic efficacy with a constant current control (CCC) or voltage control (VC) system were enrolled, and had a MICC generator implanted. All participants were followed prospectively with standardized assessments of pain (Visual Analog Scale [VAS]), condition-specific function (Oswestry Disability Index [ODI]), and quality of life (Short-Form-36) at 3 and 6 months post-implantation.
Results
Fifteen participants were eligible for inclusion; 3 were lost to follow-up. Mean VAS scores were significantly decreased at 3 months (5.3 ± 2.5, p = 0.009) and 6 months (5.1 ± 2.8, p = 0.005) relative to pre-implantation (VAS 8.3 ± 0.8). At 30 months, mean VAS remained significantly decreased (5.8 ± 1.6, p < 0.001). The mean disability score was significantly decreased at 6 months (ODI 40.5 ± 14.7, p = 0.029) compared to the mean preoperative score (53.6 ± 14.7). At 6 months, the minimum clinically important difference for VAS was met by 90% of patients and for ODI by 100%.
Conclusion
This exploratory study suggests that MICC programming may represent a reasonable short-term salvage option for patients with PSPS-2 who have lost therapeutic efficacy with a CCC or VC SCS system. A larger study is required to evaluate superiority in terms of long-term pain control of MICC versus conventional SCS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neurological Surgery, Department of Clinical Neuroscience, Corewell Health, Grand Rapids, Michigan, USA.
- Division of Clinical Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
- Michigan Pain Consultants, Grand Rapids, Michigan, USA.
Zitieren
APA
Verhey, L. H., Orozco, A. R., Mankoff, D., Elisevich, K., & Patra, S. (2025). Short-Term Patient-Reported Outcomes of Multi-Contact Independent Current Control Spinal Cord Stimulation in Patients with Chronic Low Back and Extremity Pain: An Exploratory Prospective Cohort Study. Stereotactic and Functional Neurosurgery. https://doi.org/10.1159/000546430
Vancouver
Verhey LH, Orozco AR, Mankoff D, Elisevich K, Patra S. Short-Term Patient-Reported Outcomes of Multi-Contact Independent Current Control Spinal Cord Stimulation in Patients with Chronic Low Back and Extremity Pain: An Exploratory Prospective Cohort Study. Stereotactic and Functional Neurosurgery. 2025. doi:10.1159/000546430
BibTeX
@article{Verhey2025,
author = {Verhey, Leonard H and Orozco, Andres Restrepo and Mankoff, Daniel and Elisevich, Kost and Patra, Sanjay},
title = {Short-Term Patient-Reported Outcomes of Multi-Contact Independent Current Control Spinal Cord Stimulation in Patients with Chronic Low Back and Extremity Pain: An Exploratory Prospective Cohort Study},
journal = {Stereotactic and Functional Neurosurgery},
year = {2025},
doi = {10.1159/000546430}
}
EUVIMED